EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species

TagContent
EnhancerAtlas ID
HS155-09232 
Organism
Homo sapiens 
Tissue/cell
Ovary 
Coordinate
chr21:44394780-44395900 
TF binding sites/motifs
Number: 2             
TFJASPAR IDCoordinateMotif SequenceStrand-Log10(p-value)
KLF5MA0599.1chr21:44395222-44395232GGGGCGGGGC-6.02
ZfxMA0146.2chr21:44395356-44395370CCGGCCCCGGCCTC+6.14
Number of super-enhancer constituents: 1             
IDCoordinateTissue/cell
SE_68860chr21:44394690-44396273H9
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 1             
ChromosomeStartEnd
chr214439480044395200
Enhancer Sequence
TGTCACTCAA CCGCTCCGCC GCCGCCGCCG CCGCTCTCGC CGCCGCCGTC CCTATCAATC 60
ACACCGGCCC GCGGCCGCCG CCCGCCGCCG CCGCTGCCGC CCGGGTCTGG AGGGCCGGCG 120
CTGCCCTCGA GGGCCCGCAT TTGACCCGCC GCCCGGGGCA GGGGGCGGGG AGGGGGCGCG 180
GGTGGGGGAG GGGAGCGGGC ACCCGCGGGG GAGGGGGCGC CTTCAGCCCA ACCGGCGCGG 240
GGGCGCGCCC AGTTGGTTTC TTAGTGTGGG TTGAGGGACG CGGAAATTTC TGGAAGGCGC 300
CGCCGCCGCC GCGCTGGGCC TGATCGAAGC GCGCGCTCCT AACCGTCCCT TTCGGAGTGC 360
GGCGCGCGCC CCGGCGCGGG GCGGGGGCGC GCGGAGCCCG GCGCGGGCGG GGCGGCGGGC 420
GTGAGGGTCG GGGGCGCGCG GCGGGGCGGG GCCGGGGCGG GCGGCGCGCG TGGGGCCGGT 480
CGGGTCCGCG GCCTCGCGGA GTCCTCAGGG CCGGCGGGGC TGCTCGGAGG GTGCGGGGCG 540
CGCGGCGGCG CAGGCGGGAA GATGGCGGCC GCGACCCCGG CCCCGGCCTC GGCCGTGGCG 600
AGCGGGTGGG TCGGGGTCCT GGGGGCGGTG GGCGTGATGG GGCTCGTGGC CCTCAGCCGG 660
GCGCCGGCGC GGGAGCAGCC CAGGGCCGCT CGCTGACGGC AGTGTTTGGG GCCGGGTGCT 720
GGGGAAGCGG TTCCGGCGTC CCGGGAATTG GTGGGAAGAG CCGCTTCTGT CACACGGGTC 780
GTGGTAATGG ATGACAGGAA GTGCCGGGCA GGGTCTGGGC GCCCTGTGGG TTTGCACCTT 840
CCTTGTGAGG GAAATCGTGT CACTTAACGA AAAATGAAGA AACGCGGAGT CTGCTTTATG 900
TCATCCTCGT GGCTCTCGAA ATGCCTTATT TGGACAGTGG CTCTGCGACG GGACCAGTTA 960
GGGCCTCCGT TCCGATGGCG GATTCCTGAC GGGAGGCCCG AGGGTCCGGG AATGGCGGCG 1020
TCCTGAGGTC GGGCCCAGGG CAGGCCAGGC TGAGCGCCAC GGCGGGGCCG CAGCCCTGGG 1080
GGGTGTTCCA CCTGTGTGTG GGGTTCTCTT CCAACTCTAC 1120